References

Ahmad, K., 2004. Antidepressants are sold as antiretrovirals in DR Congo. Lancet, 363: 713-713.
PubMed  |  

Akunyili, D.N., 2005. Counterfeit and substandard drugs, Nigeria's experience: Implications, challenges, actions and recommendations. Proceedings of the Meeting for Key Interest Groups on Health Organised by the World Bank, March 10-11, 2005, Washington DC., USA., pp: 1-17.

Akunyili, D.N., 2005. Counterfeit drugs and pharmacovigilance. Proceedings of the 10th Pharmacovilance the Study of Adverse Drug Reactions Training Course, May 25, 2005, Uppsala Monitoring Centre, Sweden, pp: 1-64.

Akunyili, D.N., 2007. Couterfeiting medicines: A serious crime against humanity. Proceedings of the Directora General of the National Agency for Food and Drug Administration and Control (Nafdac), April 10, 2007, Nigeria to the European Parliament in Brussels, pp: 1-7.

Aldhous, P., 2005. Murder by medicine. Nature, 434: 132-136.

Atemnkeng, M.A., K. De Cock and J. Plaizier-Vercammen, 2007. Quality control of active ingredients in artemisinin -derivative antimalarials within Kenya and DR Congo. Trop. Med. Int. Health, 12: 68-74.

Basco, L.K., P. Ringwald, A.B. Manene and J. Chandenier, 1997. False chloroquine resistance in Africa. Lancet, 350: 224-224.
CrossRef  |  

Bate, R. and K. Boateng, 2007. Bad medicine in the market. Am. Enterprise Inst. Public Policy Res., 43: 13-21.
PubMed  |  

Cars, O. and P. Nordberg, 2005. Antibiotic resistance: The faceless threat. Int. J. Risk Safety Med., 17: 103-110.
Direct Link  |  

Cockburn, R., P.N. Newton, E.K. Agyarko, D. Akunyili and N.J. White, 2005. The global threat of counterfeit drugs: Why industry and governments must communicate the dangers. PLoS Med., 2: e100-e100.
CrossRef  |  

Cohen, J.C., M. Mrazek and L. Hawkins, 2007. Tackling corruption in the pharmaceutical systems worldwide with courage and conviction. Clin. Pharmacol. Therapeutics, 81: 445-449.
Direct Link  |  

Cohen, L.E. and M. Felson, 1979. Social change and crime rate trends: A routine activity approach. Am. Sociol. Rev., 44: 588-608.
Direct Link  |  

Dondorp, A.M., P.N. Newton, M. Mayxay, W. van Damme and F.M. Smithuis et al., 2004. Fake antimalarials in Southeast Asia are a major impediment to malaria control: Multinational cross-sectional survey on the prevalence of fake antimalarials. Trop. Med. Int. Health, 9: 1241-1246.
CrossRef  |  

Felson, M., 1986. Linking Criminal Choices, Routine Activities; Informal Control and Criminal Outcomes. In: The Reasoning Criminal: Rational Choice Perspectives on Offending, Cornish, D. and R.V. Clarke (Eds.). Springer-Verlag, New York.

Felson, M., 1994. Crime and Everyday Life: Insight and Implications for Society. Pine Forge Press, Thousand Oaks, CA.

Gibson, L., 2004. Drug regulators study global treaty to tackle counterfeit drugs. Br. Med. J., 328: 486-486.
CrossRef  |  

Hanif, M., M.R. Mobarak, A. Ronan, D. Rahman, J.J. Jr. Donovan and M.L Bennish, 1995. Fatal renal failure caused by diethylene glycol in paracetamol exlixir: The Bangladesh epidemic. Br. Med. J., 311: 88-91.
Direct Link  |  

Harris, J., P. Stevens and J. Morris, 2009. Keeping it real: Combating the spread of fake drugs in poor countries. Int. Policy Network.

Meremikwu, M., U. Okomo, C. Nwachukwu, A. Oyo-Ita and J. Eke-Njoku et al., 2007. Antimalarial drug prescribing practice in private and public health faci1itis in South-East Nigeria: A descriptive study. Malaria J., 6: 55-55.
Direct Link  |  

Morris, J. and P. Stevens, 2006. Counterfeit medicines in less developed countries: Problems and solutions. Int. Policy Network.

Newton, P., S. Proux, M. Green, F. Smithuis and J. Rozendaal et al., 2001. Fake artesunate in Southeast Asia. Lancet, 357: 1948-1950.
PubMed  |  

Newton, P.N., A. Dondorp, M. Green, M. Mayxay and N.J. White, 2003. Counterfeit artesunate antirnalarials in Southeast Asia. Lancet, 362: 169-169.
CrossRef  |  

Newton, P.N., M.D. Green, F.M. Fernandez, N.P.J. Day and N.J. White, 2006. Counterfeit anti- infective drugs. Lancet Infectious Dis., 6: 602-613.
Direct Link  |  

Newton, P.N., R. McGready, F.M. Fernandez, M.D. Green and M. Sunjio et al., 2006. Manslaughter by fake artesunate in Asia: Will Africa be next. PLoS Med., 3: 197-197.
PubMed  |  

O'Brien, K.L., J.D. Selanikio, C. Hecdivert, M.F. Placide and M. Louis et al., 1998. Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. J. Am. Med. Assco., 279: 1175-1180.
CrossRef  |  

Odili, V.U., S. Osemwenkha, E.U. Eke and H.A. Okeri, 2006. Identification of counterfeit drugs by community pharmacists in Lagos State. Trop. J. Pharma. Res., 5: 545-550.
Direct Link  |  

Raufu, A., 2003. India agrees to help Nigeria tackle the import of fake drugs. Br. Med. J., 326: 1234-1234.
CrossRef  |  

Reggi, V., 2007. Counterfeit medicines: An intent to deceive: WHO News. Int. J. Risk Safety Med., 19: 105-108.
Direct Link  |  

Reidenberg, M.M. and B.A. Conner, 2001. Counterfeit and substandard drugs. Clin. Pharmacol. Therapeutics, 69: 189-193.
CrossRef  |  

Rozendaal, J., 2000. Fake antimalarials circulating in Cambodia. Bull. Mekong Malaria Forum, 7: 62-68.
Direct Link  |  

WHO, 1995. Fake drugs: A scourge of the system. WHO Drug Inf., 9: 127-129.

WHO, 2004. WHO Medicines Strategy: Countries at the Core 2004-2007. WHO, Geneva.

WHO, 2005. Combating counterfeit drugs: A concept paper for effective international collaboration. WHO Health Technology and Pharmaceuticals. September. 2005. http://www.who.int/medicines/services/counterfeit/CombatingCounterfeitDrugs_Conceptpaper.pdf.

WHO, 2006. Counterfeit medicines. Fact Sheet Revised. November 14, 2006. http://www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index.html.